Lili P.

Lili P. is an accomplished leader in artificial intelligence and machine learning, currently serving as the Head of AI/ML Portfolio Platforms at Amgen since March 2024, focusing on computational data sciences in R&D Therapeutics Discovery. Prior to this role, Lili held several positions at Biogen from March 2019 to November 2023, including Lead in Computational Biology - Human Genetics, where there was a focus on real-world data science efforts and utilizing biobank resources for research support. Additional roles at Biogen involved external innovation in data sciences and scientific ecosystem analytics to enhance clinical portfolios for neurological disorders. Lili's earlier experience includes serving as Lead Scientist at Booz Allen Hamilton, a Drug Development Informatics Analyst at AstraZeneca Pharmaceuticals, and a Postdoctoral Researcher at Stanford University, complemented by extensive education in computational chemistry and bioinformatics from prestigious institutions.